Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin versus placebo on empathy-related neurophysiology in autistic and healthy adult men
NL-OMON36342Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin in Autism Spectrum Disorder (ASD) (2 cohorts), sponsored by University Medical Center Groningen. Primary endpoints: Event-related potential responses to IAPS picture conditions, Cardiac responses to IAPS picture conditions and 1 more. Started Nov 2011; status: active, not recruiting.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NL-OMON36342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36342.